Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5830076 | 1.00 | ALDH1A1 (0.65) | ALDH1A1CA1CA2CA9USP2 | |
| SCHEMBL5553793 | 1.00 | ALDH1A1 (0.65) | ALDH1A1CA1CA2CA9USP2 | |
| SCHEMBL14778160 | 0.87 | ALDH1A1 (0.58) | ALDH1A1CA1CA2CA9USP2 | |
| SCHEMBL7785269 | 0.87 | ALDH1A1 (0.58) | ALDH1A1CA1CA2CA9USP2 | |
| SCHEMBL14779572 | 0.84 | ALDH1A1 (0.55) | ALDH1A1CA1CA2CA9USP2 | |
| SCHEMBL24753782 | 0.82 | ALDH1A1 (0.52) | ALDH1A1CA1CA2CA9USP2 | |
| SCHEMBL30422627 | 0.82 | ALDH1A1 (0.52) | ALDH1A1CA1CA2CA9USP2 | |
| SCHEMBL30067183 | 0.82 | ALDH1A1 (0.52) | ALDH1A1CA1CA2CA9USP2 | |
| SCHEMBL23249565 | 0.80 | TSHR (0.44) | ALDH1A1CA1CA2CA9TSHR | |
| SCHEMBL23249568 | 0.80 | TSHR (0.44) | ALDH1A1CA1CA2CA9TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 289 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9240614-B2 | Nonaqueous electrolyte solution and electrochemical element using same | UBE INDUSTRIES, LTD. (JP) | 2016-01-19 | — | — | US | claimed |
| EP-2579377-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | UBE INDUSTRIES (JP) | 2014-09-03 | — | — | EP | claimed |
| EP-4191727-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND POWER STORAGE DEVICE USING SAME | MU IONIC SOLUTIONS CORP (JP) | 2026-05-06 | — | — | EP | disclosed |
| EP-3772130-B1 | ADDITIVE FOR NON-AQUEOUS ELECTROLYTE SOLUTIONS, NON-AQUEOUS ELECTROLYTE SOLUTION, AND ELECTRICITY STORAGE DEVICE | SUMITOMO SEIKA CHEMICALS (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-12620622-B2 | Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same | DAIKIN INDUSTRIES, LTD. (JP) | 2026-05-05 | — | — | US | disclosed |
| US-20260112701-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION BATTERY INCLUDING NONAQUEOUS ELECTROLYTIC SOLUTION | MU IONIC SOLUTIONS CORPORATION (JP) | 2026-04-23 | — | — | US | disclosed |
| EP-4708437-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION BATTERY INCLUDING NONAQUEOUS ELECTROLYTIC SOLUTION | MU Ionic Solutions Corporation (JP) | 2026-03-11 | — | — | EP | disclosed |
| US-20260058199-A1 | NON-AQUEOUS ELECTROLYTE FOR SECONDARY BATTERY, LITHIUM ION BATTERY, AND LITHIUM ION CAPACITOR | SUMITOMO SEIKA CHEMICALS (JP) | 2026-02-26 | — | — | US | disclosed |
| US-20260024810-A1 | ADDITIVE FOR NON-AQUEOUS ELECTROLYTIC SOLUTION, NON-AQUEOUS ELECTROLYTIC SOLUTION, AND POWER STORAGE DEVICE | SUMITOMO SEIKA CHEMICALS (JP) | 2026-01-22 | — | — | US | disclosed |
| US-12500271-B2 | Non-aqueous electrolyte solution and power storage device using same | MU IONIC SOLUTIONS CORPORATION (JP) | 2025-12-16 | — | — | US | disclosed |
| US-20250266502-A1 | LITHIUM-ION BATTERY ELECTROLYTIC SOLUTION, LITHIUM-ION BATTERY, AND METHOD FOR IMPROVING BATTERY PERFORMANCE | Guangzhou Tinci Materials Technology Co., Ltd (CN) | 2025-08-21 | — | — | US | disclosed |
| US-20100041748-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. | 2010-02-18 | — | — | US | disclosed |
| US-20100041748-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. | 2010-02-18 | — | — | US | disclosed |
| WO-2010006085-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. (US) | 2010-01-14 | — | — | WO | disclosed |
| US-7629085-B2 | sulfur-containing acid ester and an alkyne-containing compound; excellent battery characteristics in cycle performance, electric capacity and storage property; e.g. 2-propynyl methyl carbonate and 1,3-propanesultone | UBE INDUSTRIES, LTD. (JP) | 2009-12-08 | — | — | US | disclosed |
| US-20070231707-A1 | Nonaqueous Electrolytic Solution and Lithium Secondary Battery | MU IONIC SOLUTIONS CORPORATION (JP) | 2007-10-04 | — | — | US | disclosed |
| EP-1772924-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND LITHIUM SECONDARY BATTERY | Ube Industries, Ltd. (JP) | 2007-04-11 | — | — | EP | disclosed |
| US-6436582-B1 | A NON-AQUEOUS SOLVENT AND (II) AN ELECTROLYTE SALT DISSOLVED THEREIN AND (III) A DISULFONATE ESTER DERIVATIVE | UBE INDUSTRIES, LTD. (JP) | 2002-08-20 | — | — | US | disclosed |
| US-5489501-A | MIXTURES OF TWO COORDINATION COMPOUNDS WHICH REACT TO FORM NEW COORDINATION COMPOUND WHILE CAUSING VISIBLE COLOR CHANGES | RICOH COMPANY, LTD. (JP) | 1996-02-06 | — | — | US | disclosed |
| US-5446011-A | Imagewise coloring when heating; mixture of n-substituted indole, aromatic polyhydroxy compound, carbonyl compound and an acid | RICOH COMPANY, LTD. (JP) | 1995-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260112701-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION BATTERY INCLUDING NONAQUEOUS ELECTROLYTIC SOLUTION | NHERF1, SLC9A2, SCNN1B | ALDH1A1 3049/4885CA1 225/4885CA2 76/4885 |
| US-20260058199-A1 | NON-AQUEOUS ELECTROLYTE FOR SECONDARY BATTERY, LITHIUM ION BATTERY, AND LITHIUM ION CAPACITOR | KCNN2, KCNN1, SLC9A1 | ALDH1A1 1262/4885CA1 135/4885CA2 125/4885 |
| US-20100041748-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | FASN, ACACA, FABP4 | ALDH1A1 285/4885CA1 2620/4885CA2 1757/4885 |
| US-12620622-B2 | Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same | ASH2L, OLA1, ODC1 | ALDH1A1 1584/4885CA1 167/4885CA2 32/4885 |
| US-20260024810-A1 | ADDITIVE FOR NON-AQUEOUS ELECTROLYTIC SOLUTION, NON-AQUEOUS ELECTROLYTIC SOLUTION, AND POWER STORAGE DEVICE | HCN1, HCN2, ESYT1 | ALDH1A1 1145/4885CA1 109/4885CA2 584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.